ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $612,741 | +398.0% | 112,447 | +513.1% | 0.00% | – |
| Q2 2023 | $123,052 | -73.1% | 18,342 | -64.6% | 0.00% | -100.0% |
| Q1 2023 | $456,959 | +22.2% | 51,754 | +6.1% | 0.00% | 0.0% |
| Q4 2022 | $374,000 | +2.5% | 48,778 | -4.8% | 0.00% | 0.0% |
| Q3 2022 | $365,000 | -18.2% | 51,226 | -7.1% | 0.00% | 0.0% |
| Q2 2022 | $446,000 | -36.2% | 55,138 | +9.3% | 0.00% | 0.0% |
| Q1 2022 | $699,000 | -53.2% | 50,467 | -5.3% | 0.00% | -66.7% |
| Q4 2021 | $1,495,000 | -15.8% | 53,293 | +1.9% | 0.00% | -25.0% |
| Q3 2021 | $1,776,000 | -16.9% | 52,301 | -0.1% | 0.00% | -20.0% |
| Q2 2021 | $2,138,000 | +17.1% | 52,337 | +15.4% | 0.01% | +25.0% |
| Q1 2021 | $1,826,000 | -27.6% | 45,334 | +6.4% | 0.00% | -42.9% |
| Q4 2020 | $2,521,000 | +1.8% | 42,608 | -16.6% | 0.01% | 0.0% |
| Q3 2020 | $2,476,000 | +5.2% | 51,115 | +5.0% | 0.01% | -12.5% |
| Q2 2020 | $2,354,000 | -53.9% | 48,670 | -73.5% | 0.01% | -61.9% |
| Q1 2020 | $5,107,000 | – | 183,780 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |